Blueprint Medicines Corporation
NASDAQ:BPMC
86 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 71.286 | 119.709 | 209.948 | 684.636 | 113.938 | 68.064 | 673.356 | 268.218 | 162.707 | 47.24 | 1.987 |
| Short Term Investments
| 639.355 | 825.283 | 267.166 | 187.213 | 369.616 | 425.948 | 273.052 | 162.09 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 710.641 | 1,078.472 | 1,034.643 | 1,549.722 | 547.96 | 494.012 | 673.356 | 268.218 | 162.707 | 47.24 | 1.987 |
| Net Receivables
| 43.178 | 36.938 | 37.03 | 25.309 | 23.412 | 0.215 | 0 | 3.577 | 3.414 | 0 | 0 |
| Inventory
| 21.223 | 29.697 | 21.817 | 8.581 | -434.022 | 0 | 0 | -54.059 | 0 | 0 | 0 |
| Other Current Assets
| 33.351 | 35.024 | -539.465 | -655.853 | 379.436 | 5.775 | 12.149 | 2.689 | 4.295 | 1.034 | 0.461 |
| Total Current Assets
| 808.393 | 1,046.651 | 554.025 | 927.759 | 516.786 | 499.787 | 685.505 | 220.425 | 170.416 | 48.274 | 2.448 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 115.65 | 115.198 | 120.862 | 101.668 | 111.114 | 29.627 | 24.363 | 6.188 | 6.661 | 1.482 | 1.404 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 94.557 | 161.269 | 557.529 | 677.873 | 64.406 | 0 | 0 | 54.059 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 30.65 | 26.784 | 19.809 | 11.093 | 15.388 | 10.71 | 5.869 | 2.123 | 1.821 | 0.169 | 0.283 |
| Total Non-Current Assets
| 240.857 | 303.251 | 698.2 | 790.634 | 190.908 | 40.337 | 30.232 | 62.37 | 8.482 | 1.651 | 1.687 |
| Total Assets
| 1,049.25 | 1,349.902 | 1,252.225 | 1,718.393 | 707.694 | 540.124 | 715.737 | 282.795 | 178.898 | 49.925 | 4.135 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 4.71 | 2.729 | 8.333 | 4.37 | 4.793 | 3.298 | 3.744 | 2.211 | 2.455 | 0.814 | 1.414 |
| Short Term Debt
| 81.409 | 27.43 | 8.093 | 7.935 | 6.823 | 1.714 | 3.232 | 3.129 | 3.844 | 1.704 | 0.708 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.812 | 448.621 | 36.576 | 12.559 | 6.16 | 3.6 | 5.373 | 11.426 | 5.898 | 3.948 | 1.007 |
| Other Current Liabilities
| 127.992 | -295.546 | 96.763 | 105.938 | 88.706 | 51.711 | 30.541 | 11.746 | 6.443 | 0.298 | 0.024 |
| Total Current Liabilities
| 214.923 | 183.234 | 149.765 | 130.802 | 106.482 | 60.323 | 42.89 | 28.512 | 18.64 | 6.764 | 3.153 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 610.962 | 215.021 | 103.315 | 81.669 | 89.126 | 14.617 | 16.331 | 3.37 | 3.948 | 7.338 | 2.155 |
| Deferred Revenue Non-Current
| 4.792 | 426.669 | 25.066 | 41.158 | 46.073 | 46.167 | 35.373 | 47.235 | 13.64 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 81.751 | 0 | 0 | -12.559 | -89.126 | -0.184 | -2.958 | -9.554 | -1.561 | 0 | 0 |
| Other Non-Current Liabilities
| 6.213 | 10.301 | 3.344 | 7.235 | 90.78 | 0.192 | 0.131 | 0.154 | 0.252 | 0.394 | 0.323 |
| Total Non-Current Liabilities
| 703.718 | 651.991 | 131.725 | 117.503 | 136.853 | 60.792 | 48.877 | 41.205 | 16.279 | 7.732 | 2.478 |
| Total Liabilities
| 918.641 | 835.225 | 281.49 | 248.305 | 243.335 | 121.115 | 91.767 | 69.717 | 34.919 | 14.496 | 5.631 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 178.898 | 114.811 | 39.958 |
| Common Stock
| 0.061 | 0.06 | 0.059 | 0.058 | 0.049 | 0.044 | 0.043 | 0.033 | 0.027 | 0.002 | 0.001 |
| Retained Earnings
| -2,339.942 | -1,832.958 | -1,275.441 | -631.356 | -945.238 | -597.545 | -355.589 | -207.47 | -134.975 | -82.206 | -41.921 |
| Accumulated Other Comprehensive Income/Loss
| -3.495 | -10.443 | -4.133 | -5.214 | -2.535 | -0.18 | -0.269 | -0.018 | -2.077 | -1.546 | -0.924 |
| Other Total Stockholders Equity
| 2,473.985 | 2,358.018 | 2,250.25 | 2,106.6 | 1,412.083 | 1,016.69 | 979.785 | 420.533 | 102.106 | 4.368 | 1.39 |
| Total Shareholders Equity
| 130.609 | 514.677 | 970.735 | 1,470.088 | 464.359 | 419.009 | 623.97 | 213.078 | 143.979 | 35.429 | -1.496 |
| Total Equity
| 130.609 | 514.677 | 970.735 | 1,470.088 | 464.359 | 419.009 | 623.97 | 213.078 | 143.979 | 35.429 | -1.496 |
| Total Liabilities & Shareholders Equity
| 1,049.25 | 1,349.902 | 1,252.225 | 1,718.393 | 707.694 | 540.124 | 715.737 | 282.795 | 178.898 | 49.925 | 4.135 |